Literature DB >> 15292635

In vitro bacterial adherence to ventriculoperitoneal shunts.

G Livni1, Y Yuhas, S Ashkenazi, S Michowiz.   

Abstract

Bacterial adherence to medical devices has been recognized as an important initial step in the infectious process, but it has not been fully elucidated regarding ventriculoperitoneal (VP) shunts. The aim of the present study was to quantitatively determine the adherence in vitro of bacteria known to cause VP shunt infections and to identify factors affecting the process. Clinical isolates studied included Staphylococcus epidermidis, Staphylococcus aureus, Streptococcus pneumoniae, and Escherichia coli. Adherence was examined quantitatively per square centimeter, visualized by electron microscopy and related to slime production and hydrophobicity. Although all four strains adhered to VP shunts, there were marked differences, with S. epidermidis and S. aureus showing the highest adherence (67.0 x 10(3) and 15.2 x 10(3) bacteria/cm(2), respectively). Factors affecting adherence included incubation time and temperature, bacterial concentration, device material (lower for silicone than Teflon), slime production and hydrophobicity. These data might be helpful for devising novel strategies to reduce VP shunt infections.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15292635     DOI: 10.1159/000078910

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  2 in total

Review 1.  Biomaterials for the central nervous system.

Authors:  Yinghui Zhong; Ravi V Bellamkonda
Journal:  J R Soc Interface       Date:  2008-09-06       Impact factor: 4.118

2.  Direct demonstration of Staphylococcus biofilm in an external ventricular drain in a patient with a history of recurrent ventriculoperitoneal shunt failure.

Authors:  Paul Stoodley; Ernest E Braxton; Laura Nistico; Luanne Hall-Stoodley; Sandra Johnson; Matthew Quigley; J Christopher Post; Garth D Ehrlich; Sandeep Kathju
Journal:  Pediatr Neurosurg       Date:  2010-07-28       Impact factor: 1.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.